Skip to main
6 Followers • 8 Following

Joni

@ucanttopmyramenHealthcare Education
  1. Asset
    Price
  2. ACAD
    ACADIA Pharma
  3. ADC Therapeutics
  4. ALX Onconology Holdings Inc
  5. AMC Entertainment
  6. AN2 Therapeutics Inc
  7. ARK Fintech Innovation ETF
  8. ARM Holdings PLC
  9. AST SpaceMobile
  10. AT&T
  11. AXT
  12. AbbVie
  13. Abbott Labs
  14. Agriforce Growing Systems Ltd
  15. Agrify
  16. Airbnb
  17. Akili Inc
  18. Alaska Air Group
  19. Alibaba
  20. Allego NV
  21. Alliance Entertainment Holding Corp
  22. Allied Gaming & Entertainment Inc
  23. Ally Financial
  24. Alnylam Pharmaceuticals
  25. Alphabet
  26. Alphabet
  27. Alpine Immune Sciences
  28. Amazon
  29. Ambev
  30. American Oncology Network Inc
  31. American Rebel Holdings Inc
  32. Ampio Pharmaceuticals Inc
  33. Apple
  34. Asensus Surgical
  35. AstraZeneca
  36. Atai Life Sciences BV
  37. Aurora Cannabis
  38. Axsome Therapeutics
  39. BAIYU Holdings Inc
  40. Babcock & Wilcox Enterprises
  41. Beneficient
  42. Benitec Biopharma Limited Sponsored ADR
  43. Berkshire Hathaway
  44. Better Home & Finance Holding Co
  45. BioNTech SE
  46. BioVie Inc
  47. Birkenstock Holding Plc
  48. Birks Group
  49. Bit Brother Ltd
  50. Bitfarms Ltd
  51. Bitwise Crypto Innovators ETF
  52. Blink Charging
  53. Block
  54. Bloom Energy
  55. Broadcom
  56. Brooge Energy Limited
  57. C3.ai
  58. C4 Therapeutics
  59. COMPASS Pathways
  60. Caesars Entertainment
  61. Cameco
  62. Canopy Growth
  63. Capital One
  64. Captivision Inc
  65. Carmell Therapeutics Corp
  66. Carnival
  67. Cassava Sciences Inc
  68. Cassava Sciences, Inc.
  69. Cava Group, Inc.
  70. Celsius Holdings
  71. Centrus Energy
  72. Checkpoint Therapeutics
  73. China Rapid Finance
  74. Cibus Inc
  75. Cidara Therapeutics
  76. Clear Secure
  77. ClimateRock
  78. Coca-Cola Bottling
  79. Codexis
  80. Coherus BioSciences
  81. Comcast
  82. Complete Solaria Inc
  83. Compugen
  84. Connect Biopharma Holdings
  85. Corcept Therapeutics
  86. Corvus Pharmaceuticals
  87. Critical Metals Corp
  88. Cronos Group
  89. Cue Biopharma
  90. Cue Health
  91. Cybin
  92. Dave
  93. Dave & Buster's
  94. Denison Mines
  95. Dick's Sporting Goods
  96. Digital Ally Inc
  97. Direct Digital Holdings
  98. Direxion Daily Electric & Autonomous Vehicles Bull 2X Shares
  99. Disney
  100. Dollar Tree
  101. DoorDash
  102. DraftKings
  103. Draganfly Inc
  104. Dyne Therapeutics
  105. EDAP TMS
  106. EOG Resources
  107. Eaton Vance Enhanced Equity Income Fund
  108. Ebix Inc
  109. EchoStar
  110. Edgio Inc
  111. Eli Lilly
  112. Emergent BioSolutions
  113. Encompass Health
  114. Endeavor Group Holdings
  115. Energy Fuels
  116. Engene Holdings Inc
  117. Envoy Medical Inc
  118. FibroGen
  119. First Trust India NIFTY 50 Equal Weight ETF
  120. FlexShares STOXX US ESG Impact Index Fund
  121. Forward Industries
  122. Frequency Therapeutics Inc
  123. Freyr Battery Inc
  124. Fusion Pharmaceuticals
  125. G1 Therapeutics
  126. GH Research PLC
  127. Gain Therapeutics
  128. Gambling.com Group
  129. Generation Bio
  130. Global X Artificial Intelligence & Technology ETF
  131. Global X Robotics & Artificial Intelligence ETF
  132. Global X Uranium ETF
  133. Globe Life Inc
  134. HeartBeam
  135. Helix Energy Solutions Group
  136. Hologic
  137. Hub Cyber Security Ltd
  138. Immix Biopharma
  139. Intellicheck
  140. Intensity Therapeutics Inc
  141. Intuitive Machines Inc
  142. Intuitive Surgical
  143. Invesco QQQ
  144. Ispire Technology Inc
  145. Janux Therapeutics
  146. Joby Aviation
  147. Just Eat Takeaway.com NV
  148. Kennedy-Wilson Holdings
  149. Keros Therapeutics
  150. Landos Biopharma
  151. Laser Photonics Corp
  152. Legacy Housing Corp
  153. Lemonade
  154. Leonardo DRS Inc
  155. Lexicon Pharmaceuticals
  156. Live Nation
  157. Lytus Technologies Holdings PTV Ltd
  158. MGM Resorts
  159. Maravai LifeSciences Holdings
  160. Mattel
  161. MercadoLibre
  162. Merck
  163. Mesoblast
  164. Meta
  165. Microsoft
  166. Mind Medicine MindMed
  167. Moderna
  168. ModivCare
  169. Modular Medical
  170. Molson Coors Brewing
  171. Momentus
  172. Montana Technologies Corporation
  173. Monte Rosa Therapeutics
  174. Moog
  175. Murano Global BV
  176. NVIDIA
  177. Nauticus Robotics Inc
  178. NeoVolta Inc
  179. NerdWallet
  180. Netflix
  181. NeueHealth Inc
  182. New Providence Acquisition Corp II
  183. Newegg Commerce
  184. Nifty India Financials ETF
  185. Noco-Noco Inc
  186. Novartis
  187. Novavax
  188. Novo Nordisk
  189. NuScale Power Corp
  190. Ocean Biomedical Inc
  191. Olink Holding AB
  192. Omega Therapeutics
  193. Owlet
  194. Palantir Technologies
  195. Palo Alto Networks
  196. Panbela Therapeutics Inc
  197. Paramount Global
  198. PayPal
  199. PepGen Inc
  200. PepsiCo
  201. Perion Network
  202. Perrigo
  203. Pfizer
  204. Pinduoduo Inc - ADR
  205. Pitney Bowes
  206. Pixelworks
  207. Privia Health Group
  208. ProShares UltraPro QQQ
  209. Progyny
  210. Quantasing Group Ltd
  211. QuantumScape
  212. RLX Technology
  213. Rani Therapeutics Holdings
  214. Reddit Inc
  215. Regeneron Pharmaceuticals
  216. Restaurant Brands
  217. Rigel Pharmaceuticals
  218. Rocket Lab USA
  219. Rocky Brands
  220. SAGE Therapeutics
  221. SHF Holdings Inc
  222. Sanmina-SCI
  223. Sanofi
  224. Sarepta Therapeutics
  225. Scinai Immunotherapeutics Ltd
  226. Seelos Therapeutics
  227. Seres Therapeutics
  228. Shattuck Labs
  229. Shengfeng Development Ltd
  230. Shiba Inu
  231. Shineco
  232. Sleep Number
  233. SoFi Technologies
  234. Solidion Technology Inc
  235. Sonoma Pharmaceuticals
  236. SoundHound AI Inc
  237. Sprott Uranium Miners ETF
  238. Strive US Energy ETF
  239. Stronghold Digital Mining
  240. Summit Wireless Technologies Inc
  241. Super League Enterprise Inc
  242. Symbotic Inc
  243. Taiwan Semiconductor Manufacturing
  244. Telomir Pharmaceuticals Inc
  245. Tema Obesity & Cardiometabolic ETF
  246. Tesla
  247. Teva Pharmaceutical
  248. The Arena Group Holdings
  249. Theravance Biopharma
  250. Topgolf Callaway Brands Corp
  251. Uber
  252. United Overseas Bank Ltd
  253. Unity Biotechnology Inc
  254. Upstart Holdings
  255. Upwork Inc
  256. Ur-Energy
  257. Uranium Royalty Corp
  258. Vast Solar Pty Ltd
  259. Verastem
  260. Verona Pharma
  261. Vertex Pharmaceuticals
  262. ViaSat
  263. Vicarious Surgical
  264. Viking Therapeutics
  265. Vintage Wine Estates
  266. Virco Mfg.
  267. Vivani Medical Inc
  268. Walgreens
  269. Walmart
  270. Wayfair
  271. Werewolf Therapeutics
  272. Xeris Biopharma Holdings
  273. iShares PHLX Semiconductor ETF
  274. iShares Robotics & Artificial Intelligence Multisector ETF
  275. salesforce.com
  1. Asset
    Price
  2. 10X Genomics
  3. AP Moller - Maersk A/S
  4. ARK Industrial Innovation ETF
  5. ASML Hld
  6. Aceragen Inc
  7. Adobe
6 Followers • 8 Following

Joni

@ucanttopmyramenHealthcare Education
Joni avatar

All of your investing.
All in one place.

Invest in stocks, treasuries, ETFs, crypto, and alternative assets on Public. Transfer your account to Public and get up to $10,000.
Sign Up
Products
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2024 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Product offerings and availability vary based on jurisdiction.

Stocks, ETFs, Options, Bonds.
Self-directed brokerage accounts and brokerage services for US-listed, registered securities, options, and Bonds, except for treasury securities offered through Jiko Securities, Inc., are offered to self-directed customers by Open to the Public Investing, Inc. (“Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Public Investing is not registered. Securities products offered by Public Investing are not FDIC insured. Apex Clearing Corporation, our clearing firm, has additional insurance coverage in excess of the regular SIPC limits. Additional information can be found here.

Options.
Certain requirements must be met in order to trade options. Options can be risky and are not suitable for all investors. Options transactions are often complex, and investors can rapidly lose the entire amount of their investment or more in a short period of time. Investors should consider their investment objectives and risks carefully before investing in options. Refer to the Characteristics and Risks of Standardized Options before considering any options transaction. Supporting documentation for any claims, if applicable, will be furnished upon request. Tax considerations with options transactions are unique and investors considering options should consult their tax advisor as to how taxes affect the outcome of each options strategy.

Options Order Flow Rebate.
If you are enrolled in our Options Order Flow Rebate Program, Public Investing will share 50% of our estimated order flow revenue for each completed options trade as a rebate to help reduce your trading costs. The exact rebate will depend on the specifics of each transaction and will be previewed for you prior to submitting each trade. This rebate will be deducted from your cost to place the trade and will be reflected on your trade confirmation. Order flow rebates are not available for non-options transactions. To learn more, see our Fee Schedule, Order Flow Rebate FAQ, and Order Flow Rebate Program Terms & Conditions.

Bonds.
“Bonds” shall refer to corporate debt securities and U.S. government securities offered on the Public platform through a self-directed brokerage account held at Public Investing and custodied at Apex Clearing. For purposes of this section, Bonds exclude treasury securities held in treasury accounts with Jiko Securities, Inc. as explained under the “ Treasury Accounts” section.

Investments in Bonds are subject to various risks including risks related to interest rates, credit quality, market valuations, liquidity, prepayments, early redemption, corporate events, tax ramifications and other factors. The value of Bonds fluctuate and any investments sold prior to maturity may result in gain or loss of principal. In general, when interest rates go up, Bond prices typically drop, and vice versa. Bonds with higher yields or offered by issuers with lower credit ratings generally carry a higher degree of risk. All fixed income securities are subject to price change and availability, and yield is subject to change. Bond ratings, if provided, are third party opinions on the overall bond's credit worthiness at the time the rating is assigned. Ratings are not recommendations to purchase, hold, or sell securities, and they do not address the market value of securities or their suitability for investment purposes.

High-Yield Cash Account.
A High-Yield Cash Account is a secondary brokerage account with Public Investing. Funds in your High-Yield Cash Account are automatically deposited into partner banks (“Partner Banks”), where that cash earns interest and is eligible for FDIC insurance. See here for a list of current Partner Banks. Your Annual Percentage Yield is variable and may change at the discretion of the Partner Banks or Public Investing. Apex Clearing and Public Investing receive administrative fees for operating this program, which reduce the amount of interest paid on swept cash. Neither Public Investing nor any of its affiliates is a bank. Learn more.

Alternative Assets.
Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). This content is not investment advice. These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. Alternative Assets purchased on the Public platform are not held in a Public Investing brokerage account and are self-custodied by the purchaser. The issuers of these securities may be an affiliate of Public Investing, and Public Investing (or an affiliate) may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.

Cryptocurrency.
Cryptocurrency trading, execution, and custody services are provided by Bakkt Crypto Solutions, LLC (NMLS ID 1828849) (“Bakkt”). Cryptocurrency is highly speculative, involves a high degree of risk, and has the potential for loss of the entire amount of an investment. Cryptocurrencies offered by Bakkt are not securities and are not FDIC insured or protected by SIPC. Your cryptocurrency assets are held in your Bakkt account. Bakkt is a licensed virtual currency business by the New York State Department of Financial Services and a licensed money transmitter, but is not a registered broker-dealer or a FINRA member. Your Bakkt Crypto account is separate from your brokerage account with Public Investing, which holds US-listed stocks and ETFs. Please review the Risk Disclosures before trading.

Treasury Accounts.
Investing services in treasury accounts offering 6 month US Treasury Bills on the Public platform are through Jiko Securities, Inc. (“JSI”), a registered broker-dealer and member of FINRA & SIPC. See JSI’s FINRA BrokerCheck and Form CRS for further information.

JSI uses funds from your Treasury Account to purchase T-bills in increments of $100 “par value” (the T-bill’s value at maturity). T-bills are purchased at a discount to the par value and the T-bill’s yield represents the difference in price between the “par value” and the “discount price.” Aggregate funds in your Treasury Account in excess of the T-bill purchases will remain in your Treasury Account as cash. The value of T-bills fluctuate and investors may receive more or less than their original investments if sold prior to maturity. T-bills are subject to price change and availability - yield is subject to change. Past performance is not indicative of future performance. Investments in T-bills involve a variety of risks, including credit risk, interest rate risk, and liquidity risk. As a general rule, the price of a T-bills moves inversely to changes in interest rates. Although T-bills are considered safer than many other financial instruments, you could lose all or a part of your investment. See Jiko U.S. Treasuries Risk Disclosures for further details.

Investments in T-bills: Not FDIC Insured; No Bank Guarantee; May Lose Value.

Banking services and bank accounts are offered by Jiko Bank, a division of Mid-Central National Bank.

JSI and Jiko Bank are not affiliated with Public Holdings, Inc. (“Public”) or any of its subsidiaries. None of these entities provide legal, tax, or accounting advice. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Commission-free trading refers to $0 commissions charged on trades of US listed registered securities placed during the US Markets Regular Trading Hours in self-directed brokerage accounts offered by Public Investing. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Public’s Investing’s Fee Schedule to learn more.

Fractional shares are illiquid outside of Public and not transferable. For a complete explanation of conditions, restrictions and limitations associated with fractional shares, see our Fractional Share Disclosure to learn more.

Investment Plans. US members only. Investment Plans (“Plans”) shown in our marketplace are for informational purposes only and are meant as helpful starting points as you discover, research and create a Plan that meets your specific investing needs. Plans are self-directed purchases of individually-selected assets, which may include stocks, ETFs and cryptocurrency. Plans are not recommendations of a Plan overall or its individual holdings or default allocations. Plans are created using defined, objective criteria based on generally accepted investment theory; they are not based on your needs or risk profile. You are responsible for establishing and maintaining allocations among assets within your Plan. Plans involve continuous investments, regardless of market conditions. Diversification does not eliminate risk. See our Investment Plans Terms and Conditions and Sponsored Content and Conflicts of Interest Disclosure.

Market Data. Quotes and other market data for Public’s product offerings are obtained from third party sources believed to be reliable, but Public makes no representation or warranty regarding the quality, accuracy, timeliness, and/or completeness of this information. Such information is time sensitive and subject to change based on market conditions and other factors. You assume full responsibility for any trading decisions you make based upon the market data provided, and Public is not liable for any loss caused directly or indirectly by your use of such information. Market data is provided solely for informational and/or educational purposes only. It is not intended as a recommendation and does not represent a solicitation or an offer to buy or sell any particular security.